TG Therapeutics (NASDAQ:TGTX) CEO Mike Weiss made a good impression at the J.P. Morgan Healthcare Conference this week. The company started the presentation day with an initially poorly received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback